Fairscale Capital, LLC Ark Genomic Revolution ETF (De Transaction History
Fairscale Capital, LLC
- $113 Billion
- Q2 2024
A detailed history of Fairscale Capital, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Fairscale Capital, LLC holds 642 shares of ARKG stock, worth $16,300. This represents 0.02% of its overall portfolio holdings.
Number of Shares
642Holding current value
$16,300% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
292Shares Held
21.6MCall Options Held
2.79MPut Options Held
6.56M-
Jpmorgan Chase & CO New York, NY2.96MShares$75 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$69.9 Million3.23% of portfolio
-
Ubs Group Ag1.75MShares$44.4 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$39 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$37 Million0.0% of portfolio